Global Biologics and Biosimilars Market Research Report 2021
Global Biologics and Biosimilars Market Research Report 2021
Analysis of the Biologics and Biosimilars Market reveals emerging trends, consumer adoption rates, and competitive strategies among leading manufacturers worldwide.
Exclusive deal : 20% Instant discount on Direct purchases! Don't wait—claim your discount today!
Research Predicts that Biologics and Biosimilars Market was valued USD xxxx unit in 2020 and is expected to reach USD xxxx Unit by the year 2025, growing at a CAGR of xx% globally.
Global Biologics and Biosimilars Market Overview:
Global Biologics and Biosimilars Market Report 2020 comes with the extensive industry analysis of development components, patterns, flows and sizes. The report also calculates present and past market values to forecast potential market management through the forecast period between 2020-2025.This research study of Biologics and Biosimilars involved the extensive usage of both primary and secondary data sources. This includes the study of various parameters affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry.
Impact of COVID-19 on Biologics and Biosimilars Market
Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost every country around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affected the Biologics and Biosimilars market in 2020.
Global Biologics and Biosimilars Market Segmentation
By Type, Biologics and Biosimilars market has been segmented into:
Bio-PET
PHA
Bio-PE
Starch Blends
PLA
Others
By Application, Biologics and Biosimilars market has been segmented into:
Packing Industry
Automotive Industry
Bottles manufacturing
Others
Regional Analysis:
North America (U.S., Canada, Mexico)
Europe (Germany, U.K., France, Italy, Russia, Spain etc.)
Asia-Pacific (China, India, Japan, Southeast Asia etc.)
South America (Brazil, Argentina etc.)
Middle East & Africa (Saudi Arabia, South Africa etc.)
Top Key Players Covered in Biologics and Biosimilars market are:
NatureWorks
Braskem
BASF
Arkema
DuPont
Novamont
Corbion
Metabolix
PSM
PolyOne
Biome Bioplastics
Biomer
FKuR
Trellis Bioplastics
Kingfa
Cardia Bioplastics
Grabio
MHG
Myriant
Mitsubishi
Zhejiang Hisun Biomaterials
1. Market Overview of Biologics and Biosimilars
1.1 Biologics and Biosimilars Market Overview
1.1.1 Biologics and Biosimilars Product Scope
1.1.2 Market Status and Outlook
1.2 Biologics and Biosimilars Market Size by Regions: 2015 VS 2021 VS 2026
1.3 Biologics and Biosimilars Historic Market Size by Regions (2015-2020)
1.4 Biologics and Biosimilars Forecasted Market Size by Regions (2021-2026)
1.5 Covid-19 Impact on Key Regions, Keyword Market Size YoY Growth (2015-2026)
1.5.1 North America
1.5.2 East Asia
1.5.3 Europe
1.5.4 South Asia
1.5.5 Southeast Asia
1.5.6 Middle East
1.5.7 Africa
1.5.8 Oceania
1.5.9 South America
1.5.10 Rest of the World
1.6 Coronavirus Disease 2019 (Covid-19) Impact Will Have a Severe Impact on Global Growth
1.6.1 Covid-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections
1.6.2 Covid-19 Impact: Commodity Prices Indices
1.6.3 Covid-19 Impact: Global Major Government Policy
2. Covid-19 Impact Biologics and Biosimilars Sales Market by Type (2015-2026)
2.1 Global Biologics and Biosimilars Historic Market Size by Type (2015-2020)
2.2 Global Biologics and Biosimilars Forecasted Market Size by Type (2021-2026)
2.3 Bio-PET
2.4 PHA
2.5 Bio-PE
2.6 Starch Blends
2.7 PLA
2.8 Others
3. Covid-19 Impact Biologics and Biosimilars Sales Market by Application (2015-2026)
3.1 Global Biologics and Biosimilars Historic Market Size by Application (2015-2020)
3.2 Global Biologics and Biosimilars Forecasted Market Size by Application (2021-2026)
3.3 Packing Industry
3.4 Automotive Industry
3.5 Bottles manufacturing
3.6 Others
4. Covid-19 Impact Market Competition by Manufacturers
4.1 Global Biologics and Biosimilars Production Capacity Market Share by Manufacturers (2015-2020)
4.2 Global Biologics and Biosimilars Revenue Market Share by Manufacturers (2015-2020)
4.3 Global Biologics and Biosimilars Average Price by Manufacturers (2015-2020)
5. Company Profiles and Key Figures in Biologics and Biosimilars Business
5.1 NatureWorks
5.1.1 NatureWorks Company Profile
5.1.2 NatureWorks Biologics and Biosimilars Product Specification
5.1.3 NatureWorks Biologics and Biosimilars Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.2 Braskem
5.2.1 Braskem Company Profile
5.2.2 Braskem Biologics and Biosimilars Product Specification
5.2.3 Braskem Biologics and Biosimilars Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.3 BASF
5.3.1 BASF Company Profile
5.3.2 BASF Biologics and Biosimilars Product Specification
5.3.3 BASF Biologics and Biosimilars Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.4 Arkema
5.4.1 Arkema Company Profile
5.4.2 Arkema Biologics and Biosimilars Product Specification
5.4.3 Arkema Biologics and Biosimilars Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.5 DuPont
5.5.1 DuPont Company Profile
5.5.2 DuPont Biologics and Biosimilars Product Specification
5.5.3 DuPont Biologics and Biosimilars Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.6 Novamont
5.6.1 Novamont Company Profile
5.6.2 Novamont Biologics and Biosimilars Product Specification
5.6.3 Novamont Biologics and Biosimilars Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.7 Corbion
5.7.1 Corbion Company Profile
5.7.2 Corbion Biologics and Biosimilars Product Specification
5.7.3 Corbion Biologics and Biosimilars Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.8 Metabolix
5.8.1 Metabolix Company Profile
5.8.2 Metabolix Biologics and Biosimilars Product Specification
5.8.3 Metabolix Biologics and Biosimilars Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.9 PSM
5.9.1 PSM Company Profile
5.9.2 PSM Biologics and Biosimilars Product Specification
5.9.3 PSM Biologics and Biosimilars Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.10 PolyOne
5.10.1 PolyOne Company Profile
5.10.2 PolyOne Biologics and Biosimilars Product Specification
5.10.3 PolyOne Biologics and Biosimilars Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.11 Biome Bioplastics
5.11.1 Biome Bioplastics Company Profile
5.11.2 Biome Bioplastics Biologics and Biosimilars Product Specification
5.11.3 Biome Bioplastics Biologics and Biosimilars Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.12 Biomer
5.12.1 Biomer Company Profile
5.12.2 Biomer Biologics and Biosimilars Product Specification
5.12.3 Biomer Biologics and Biosimilars Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.13 FKuR
5.13.1 FKuR Company Profile
5.13.2 FKuR Biologics and Biosimilars Product Specification
5.13.3 FKuR Biologics and Biosimilars Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.14 Trellis Bioplastics
5.14.1 Trellis Bioplastics Company Profile
5.14.2 Trellis Bioplastics Biologics and Biosimilars Product Specification
5.14.3 Trellis Bioplastics Biologics and Biosimilars Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.15 Kingfa
5.15.1 Kingfa Company Profile
5.15.2 Kingfa Biologics and Biosimilars Product Specification
5.15.3 Kingfa Biologics and Biosimilars Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.16 Cardia Bioplastics
5.16.1 Cardia Bioplastics Company Profile
5.16.2 Cardia Bioplastics Biologics and Biosimilars Product Specification
5.16.3 Cardia Bioplastics Biologics and Biosimilars Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.17 Grabio
5.17.1 Grabio Company Profile
5.17.2 Grabio Biologics and Biosimilars Product Specification
5.17.3 Grabio Biologics and Biosimilars Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.18 MHG
5.18.1 MHG Company Profile
5.18.2 MHG Biologics and Biosimilars Product Specification
5.18.3 MHG Biologics and Biosimilars Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.19 Myriant
5.19.1 Myriant Company Profile
5.19.2 Myriant Biologics and Biosimilars Product Specification
5.19.3 Myriant Biologics and Biosimilars Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.20 Mitsubishi
5.20.1 Mitsubishi Company Profile
5.20.2 Mitsubishi Biologics and Biosimilars Product Specification
5.20.3 Mitsubishi Biologics and Biosimilars Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.21 Zhejiang Hisun Biomaterials
5.21.1 Zhejiang Hisun Biomaterials Company Profile
5.21.2 Zhejiang Hisun Biomaterials Biologics and Biosimilars Product Specification
5.21.3 Zhejiang Hisun Biomaterials Biologics and Biosimilars Production Capacity, Revenue, Price and Gross Margin (2015-2020)
6. North America
6.1 North America Biologics and Biosimilars Market Size (2015-2026)
6.2 North America Biologics and Biosimilars Key Players in North America (2015-2020)
6.3 North America Biologics and Biosimilars Market Size by Type (2015-2020)
6.4 North America Biologics and Biosimilars Market Size by Application (2015-2020)
7. East Asia
7.1 East Asia Biologics and Biosimilars Market Size (2015-2026)
7.2 East Asia Biologics and Biosimilars Key Players in North America (2015-2020)
7.3 East Asia Biologics and Biosimilars Market Size by Type (2015-2020)
7.4 East Asia Biologics and Biosimilars Market Size by Application (2015-2020)
8. Europe
8.1 Europe Biologics and Biosimilars Market Size (2015-2026)
8.2 Europe Biologics and Biosimilars Key Players in North America (2015-2020)
8.3 Europe Biologics and Biosimilars Market Size by Type (2015-2020)
8.4 Europe Biologics and Biosimilars Market Size by Application (2015-2020)
9. South Asia
9.1 South Asia Biologics and Biosimilars Market Size (2015-2026)
9.2 South Asia Biologics and Biosimilars Key Players in North America (2015-2020)
9.3 South Asia Biologics and Biosimilars Market Size by Type (2015-2020)
9.4 South Asia Biologics and Biosimilars Market Size by Application (2015-2020)
10. Southeast Asia
10.1 Southeast Asia Biologics and Biosimilars Market Size (2015-2026)
10.2 Southeast Asia Biologics and Biosimilars Key Players in North America (2015-2020)
10.3 Southeast Asia Biologics and Biosimilars Market Size by Type (2015-2020)
10.4 Southeast Asia Biologics and Biosimilars Market Size by Application (2015-2020)
11. Middle East
11.1 Middle East Biologics and Biosimilars Market Size (2015-2026)
11.2 Middle East Biologics and Biosimilars Key Players in North America (2015-2020)
11.3 Middle East Biologics and Biosimilars Market Size by Type (2015-2020)
11.4 Middle East Biologics and Biosimilars Market Size by Application (2015-2020)
12. Africa
12.1 Africa Biologics and Biosimilars Market Size (2015-2026)
12.2 Africa Biologics and Biosimilars Key Players in North America (2015-2020)
12.3 Africa Biologics and Biosimilars Market Size by Type (2015-2020)
12.4 Africa Biologics and Biosimilars Market Size by Application (2015-2020)
13. Oceania
13.1 Oceania Biologics and Biosimilars Market Size (2015-2026)
13.2 Oceania Biologics and Biosimilars Key Players in North America (2015-2020)
13.3 Oceania Biologics and Biosimilars Market Size by Type (2015-2020)
13.4 Oceania Biologics and Biosimilars Market Size by Application (2015-2020)
14. South America
14.1 South America Biologics and Biosimilars Market Size (2015-2026)
14.2 South America Biologics and Biosimilars Key Players in North America (2015-2020)
14.3 South America Biologics and Biosimilars Market Size by Type (2015-2020)
14.4 South America Biologics and Biosimilars Market Size by Application (2015-2020)
15. Rest of the World
15.1 Rest of the World Biologics and Biosimilars Market Size (2015-2026)
15.2 Rest of the World Biologics and Biosimilars Key Players in North America (2015-2020)
15.3 Rest of the World Biologics and Biosimilars Market Size by Type (2015-2020)
15.4 Rest of the World Biologics and Biosimilars Market Size by Application (2015-2020)
16 Biologics and Biosimilars Market Dynamics
16.1 Covid-19 Impact Market Top Trends
16.2 Covid-19 Impact Market Drivers
16.3 Covid-19 Impact Market Challenges
16.4 Porter’s Five Forces Analysis
18 Regulatory Information
17 Analyst's Viewpoints/Conclusions
18 Appendix
18.1 Research Methodology
18.1.1 Methodology/Research Approach
18.1.2 Data Source
18.2 Disclaimer
Research Methodology:
Biologics and Biosimilars Market Size Estimation
To estimate market size and trends, we use a combination of top-down and bottom-up methods. This allows us to evaluate the market from various perspectives—by company, region, product type, and end users.
Our estimates are based on actual sales data, excluding any discounts. Segment breakdowns and market shares are calculated using weighted averages based on usage rates and average prices. Regional insights are determined by how widely a product or service is adopted in each area.
Key companies are identified through secondary sources like industry reports and company filings. We then verify revenue estimates and other key data points through primary research, including interviews with industry experts, company executives, and decision-makers.
We take into account all relevant factors that could influence the market and validate our findings with real-world input. Our final insights combine both qualitative and quantitative data to provide a well-rounded view. Please note, these estimates do not account for unexpected changes such as inflation, economic downturns, or policy shifts.
Data Source
Secondary Sources
This study draws on a wide range of secondary sources, including press releases, annual reports, non-profit organizations, industry associations, government agencies, and customs data. We also referred to reputable databases and directories such as Bloomberg, Wind Info, Hoovers, Factiva, Trading Economics, Statista, and others. Additional references include investor presentations, company filings (e.g., SEC), economic data, and documents from regulatory and industry bodies.
These sources were used to gather technical and market-focused insights, identify key players, analyze market segmentation and classification, and track major trends and developments across industries.
| Market Size |
|
|
| Market Position of Top Company |
|
|
| Qualitative Analysis |
|
|
Primary Sources
As part of our primary research, we interviewed a variety of stakeholders from both the supply and demand sides to gather valuable qualitative and quantitative insights.
On the supply side, we spoke with product manufacturers, competitors, industry experts, research institutions, distributors, traders, and raw material suppliers. On the demand side, we engaged with business leaders, marketing and sales heads, technology and innovation directors, supply chain executives, and end users across key organizations.
These conversations helped us better understand market segmentation, pricing, applications, leading players, supply chains, demand trends, industry outlook, and key market dynamics—including risks, opportunities, barriers, and strategic developments.
Key Data Information from Primary Sources
| Primary Sources | Parameters | Key Data |
| Market Segments(by Application, by Type) |
|
|
| Total Market |
|
|